MetLife Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.79M | Sell |
|
|||||
|
2025
Q1 | $1.86M | Sell |
|
|||||
|
2024
Q4 | $2.94M | Buy |
|
|||||
|
2024
Q3 | $1.71M | Sell |
|
|||||
|
2024
Q2 | $1.71M | Buy |
|
|||||
|
2024
Q1 | $893K | Hold |
|
|||||
|
2023
Q4 | $660K | Hold |
|
|||||
|
2023
Q3 | $645K | Hold |
|
|||||
|
2023
Q2 | $476K | Hold |
|
|||||
|
2023
Q1 | $560K | Sell |
|
|||||
|
2022
Q4 | $691K | Hold |
|
|||||
|
2022
Q3 | $611K | Hold |
|
|||||
|
2022
Q2 | $570K | Hold |
|
|||||
|
2022
Q1 | $711K | Hold |
|
|||||
|
2021
Q4 | $607K | Hold |
|
|||||
|
2021
Q3 | $738K | Hold |
|
|||||
|
2021
Q2 | $750K | Hold |
|
|||||
|
2021
Q1 | $874K | Sell |
|
|||||
|
2020
Q4 | $860K | Hold |
|
|||||
|
2020
Q3 | $803K | Buy |
|
|||||
|
2020
Q2 | $961K | Hold |
|
|||||
|
2020
Q1 | $700K | Hold |
|
|||||
|
2019
Q4 | $764K | Hold |
|
|||||
|
2019
Q3 | $536K | Hold |
|
|||||
|
2019
Q2 | $720K | Buy |
|
|||||
|
2019
Q1 | $1.1M | Hold |
|
|||||
|
2018
Q4 | $1.08M | Hold |
|
|||||
|
2018
Q3 | $1.52M | Hold |
|
|||||
|
2018
Q2 | $1.71M | Buy |
|
|||||
|
2018
Q1 | $1.07M | Sell |
|
|||||
|
2017
Q4 | $1.33M | Buy |
|